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The objective of the present study was screening of 3-
hydroxy-3- methyl glutaryl Co A (HMG CoA) 
reductase inhibitor producing marine actinomycetes. A 
total of 65 morphologically different actinomycetes 
were screened for HMG CoA  reductase inhibitor 
production  in a two stage submerged fermentation 
and evaluated for HMG CoA  reductase inhibitor 
activity  by agar diffusion and thin layer 
chromatography technique using lovostatin as a 
control. Among 65 marine Actinomycete strains, only 
one strain produced HMG Co A reductase inhibitor. 
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Hypercholesterolemia involves heterogeneous 
disorders of lipid metabolism characterized by 
elevated levels of plasma total cholesterol and low 
density lipoprotein (LDL) derived cholesterol. 
Cholesterol enters the body in two ways i,e. absorption 
from diet or endogenous biosynthesis. The 
interference of either process would provide an 
effective means of lowering plasma total cholesterol. 
3-Hydroxy- 3 -methyl glutaryl Co enzyme A (HMG 
Co A) reductase, a rate limiting enzyme in cholesterol 
biosynthetic pathway, was considered a promising 
target of inhibition. Structurally related compounds 
such as compactin (ML 236B)  and mevinolin 
(monacolin K) were discovered from fungal culture 
broths as potent and specific inhibitors of HMG Co A 
reductase 2,3,4,5 Since then, the derivatives  lovastatin, 
pravastatin and mevinolin have been used clinically 
for the treatment of hypercholesterolemia 6  . 
 
Statins are a class of organic molecules which posses 
polyketide structure and a hydroxyl naphthalene ring 
system with different side chains. Statins are produced 
as secondary metabolites by microorganisms like 
bacteria 9(Bacillus spp.), Fungi10, 11,4,12 (Aspergillus 
spp, Monascus spps.)And Actinomycete spp.13, 14 
(Streptomyces spp, Actinomadura spp). The aim of the 
present study is to isolate actinomycetes from marine 
environment and screen for HMG Co A reductase 
inhibitor activity. 
                             
 
MATERIALS AND METHODS 
 
 Isolation of marine actinomycetes: 
Marine water and sediment samples were collected 
from different places of Bay of Bengal, 
Visakhapatnam. Samples were processed on the same 
day of collection. One gram or one milliliter (1ml) of 
sample was suspended in 10 ml of sterile 5mM 
phosphate buffer (pH=7.0) and stirred for 1 min in a 
super mixer. A 10-fold serial dilution of the 
suspension was made. One ml of the suspension was 
spread on starch casein agar plate (g/l: Starch 19, 
Casein 0.3,KNO3  2, NaCl  2, K2HPO4  2 
,MgSO4.7H2O  0.05,CaCo3 0.02,FeSO4.7H20  0.01,  
agar  20)   and  Oat meal agar (g/l: Oat meal 20, agar 
20, trace salt solution 1ml) plate and incubated at 280C 
for 21 days. 
Starch casein agar and Oat meal agar were 
supplemented with Cycloheximide 50 µg/ml and 
5µg/ml rifampicin to inhibit fungal and bacterial 
contamination respectively. 
 
Identification of Actinomycetes 
 Actinomycetes were recognized by their characteristic 
tough leathery colonies that adhered to the agar 
surface, branched vegetative mycelia, and when 
present, aerial mycelia and spore formation. 
Actinomycete colonies were characterized 
morphologically and physiologically following 
methods given in the International streptomyces 
Project (ISP) .Actinomycete isolate SS16/4 was 












Screening of HMG Co A reductase inhibitors 
 
The selected isolate SS16/ 4 was   grown on YEME 
(ISP 2 media) agar slant for 5-7 days. 5 ml of a spore 
suspension  was added  to a 100 ml shake flask 
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containing 20 ml of the seed medium (for every liter: 
glucose 10 g, peptone 2g, soy protein 4 g and KH2Po4 
1 g ,PH 7.0 +_0.2). The seed culture was incubated at 
270 C for 24 to 48 hrs in a rotary shaker at 200 to 220 
rpm.  2to 5 ml of the seed culture was  transferred to a 
250ml shake flask containing 50 ml of the 
fermentation medium (per liter: glucose 15 g, peptone 
5 g, corn steep powder (C.S.P.) 5 g and soybean meal 
4 g, KH2PO4  1 g, P
H 7.0+.0.2). The flasks were 
incubated at 270C for 5-7days on a rotary shaker at 
200 rpm  
 
Extraction 
After incubation, production media was centrifuged at 
1500 rpm for 15 min at 100C in cooling centrifuge, to 
separate fermented broth (supernatant) and mycelium. 
 
Before extraction , supernatant  obtained by 
centrifugation was acidified to  different  pH  values  
of 3,5,7,9 with 1N HCl and extracted with ethyl 
acetate 15,12 
 The mycelia mass obtained by centrifugation was 
stirred with ethyl acetate at room temparture for 1hr, 
acidified to PH 3 with 1N HCl and extracted with ethyl 
acetate15, 12.  Extracted product was centrifuged at 
1500 rpm and the organic phase was collected, and 
concentrated in rotary evaporator (Heidolph). 
Concentrated product was used for further studies16. 
 
Thin Layer Chromatography(TLC) 
 
TLC was used to detect the presence of HMG Co A 
reductase inhibitor in the extract.30 µl of concentrated 
product was applied to precoated silica gel plate. After 
the chromatogram was developed in the mobile phase 
(dicholarmethane and ethyl acetate 70:30 v/v) it was 
stained with iodine vapour and observed under UV 
light.  Three lovastatin standard spots were applied for 
comparison of the Rf values 16,17. The lovastatin 
standard compound was provided by Dr.Reddys 
laboratories. The lovastatin stock standard was 
prepared from the pure lactone form of the compound 
and   dissolved in acetonitrile at a concentration of 
500µg/ml. 1:10 dilution of the stock solution in the  
same diluent  was used as working standard 16. 
Bio-assay of HMG Co A reductase inhibitor using 
Neurospora crassa:-. Neurospora crassa was grown 
for 7-10 days on PDA slants at 280C; spores were 
harvested with sterile water. Twenty µl of spore 
suspension  of Neurospora crassa was transferred into 
a 40×40 mm size sterilized petri plate with PDA 
medium ( g/l : Potatoes  200g ,Dextrose  20g  ,agar  
15g ). After solidification, wells were made using 
8mm diameter borer18. 
Bio-assay of HMG Co A reductase inhibitor using 
Candida albicans: - Candida albicans   was grown for 
12 hrs on PDA slants at 280C, spores were harvested 
with sterile water. 20µl of spore suspension of 
Candida albicans was taken into 40×40 mm size 
sterilized petri plate with PDA medium.  After 




 RESULTS AND DISCUSSION 
 
The aim of study was to screen the HMG Co A 
reductase inhibitor producing marine actinomycetes. A 
total of 65 marine actinomycetes were screened for 
HMG Co A reductase inhibitor activity.  
 The fermentation broths obtained from 65 marine 
isolates were   examined by TLC. Lovastatin was used 
as the standard compound having HMG Co A 
reductase inhibitor activity. Only one of the isolate 
SS16/4 was detected by chromatography to contain 
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Table -1.  Rf values of standard and test samples in different solvents 
 
 
    Solvent 
 
     Rf of  standard 
 
Test Organism 
      (Lovastatin)     SS16/4 
  
              A  
          0.67 
 
     0.67 
  
               B.  
 
 
          0.55 
 
     0.55 
 
              C 
 
          0.50                              . 
 
       0.50     . 
 
 
A: Dichloromethane: ethyl acetate (70:30v/v) 
B.Ethyl acetate: Hexane: acetic acid (70:30:6) 
C.Acetonitrile:hexane.acetic acid (30:70:6) 
 




 Figure-1  Bio-assay using   Neurospora crassa as test organism 
 
 
Zone of inhibition of the 
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The wells in the Petri plates were bored sufficiently 
apart to prevent coalescence of the zones of inhibition 
of the extract and lovastatin. Ethyl acetate was used as 
the control and it did not show any inhibition zone. 
The assay was carried out for the broth (extra cellular) 
and mycelium (intracellular) separately and inhibition 
zones were recorded. Zones of inhibition for SS16/4 
are shown in fig 1. 
The optimum amount of lovastatin required to produce 
a zone of 10mm was 50µl(1mg/ml) and these  
concentrations were  used to validate each N.crassa 
bioassay method. The period of incubation of N.crassa 
was critical for this test, as incubation beyond the 
specified period resulted in overgrowth and the 
boundaries of inhibition zone could not be clearly 
measured. Best results were obtained with plates 
incubated for 16-18 hrs at 280C. The zones of 
inhibition of the test extracts and standard were 
measured and recorded, as shown in table2. 
 
Standard lovastatin inhibition zone    = 10 mm 
Ethyl acetate inhibition zone          = 0 mm 
 
Table-2. The activity of mycelial  pellet and culture filtrate of SS16/4 against     
N. crassa  
 
 
   Isolate 
 
      Inhibition zones (mm) 
 
PH 3(Mycelium) PH 3(broth) 
SS16/4       20     10 
 
              
 
In the bioassay plate method using C.albicans as the 
test organism, lovastatin causes inhibition of growth at 
a concentration of 50µl (1mg/ml). The broth (extra 
cellular) and mycelium (intracellular) extracts of 
SS16/4 were assayed separately .The plates were 
incubated for 10-16 hrs and zones of inhibition were 
measured19 as shown in fig2 and table3. 
Standard lovastatin inhibition zone   = 15 mm 
















Table-3. The activity of mycelial pellet and culture filtrate of SS16/4 against     






    Inhibition zones in ( mm)                                 
 
PH 3 (Mycelium) PH 3 (Broth) 
SS16/4          22     10 
 
 








Zone of inhibition of the 












The aim of study was to screen HMG Co A reductase 
inhibitor producing marine actinomycetes. A total of 
65 different marine actinomycetes were screened 
.Among them, only one strain SS16/4 showed positive 
results in TLC which was later confirmed by bioassay 
plate method. 
 
Disregarding small modifications in fermentation 
conditions this study differs from those of Shindia 20 
and Gunde Cimerman et al 21 in which they used 
methanol extraction of acidified broth followed by 
TLC analysis. Where as ethyl acetate extracts of 
acidified fermentation broth and mycelium were used 
for TLC and Bio-assay plate technique in our study.  
By using ethyl acetate to extract HMG Co A reductase 
inhibitor from acidified fermentation broth and 
mycelium it was possible to extract a significant 
amount of the inhibitior. Further it was observed that 
when the mycelium was extracted at PH 3 large 
inhibition zones were observed against N.crassa and 
C.albicans (Figure-1 and 2). However, when the broth 
was extracted at different PH   values of  3,5,7,9, only 
small zones of inhibition wa observed for the broth 
with PH 3 (Table-2 and 3). 
 
The nutritional and cultural conditions employed in 
this study were appropriate for screening HMG Co A 
reductase inhibitor production by the isolate 
SS16/4.Optimizing the medium may be necessary for 
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